Chandar Abboy, MD
Critical Care Medicine · Fayetteville, NCNPI 1275583585
Payments from drug & device makers
Across 231 payments — averaging $19,063 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$2M
- Eli Lilly$1.9M
- GSK$254K
- Hikma Pharmaceuticals USA$91K
- AstraZeneca$69K
- Cipla USA Inc.$41K
- plus $49K from 21 others
Across 17 payments — averaging $22,203 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$374K
- GSK$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 108 | $1,986,238 |
| Eli Lilly | 29 | $1,912,982 |
| GSK | 24 | $254,450 |
| Hikma Pharmaceuticals USA | 6 | $90,710 |
| AstraZeneca | 8 | $68,637 |
| Cipla USA Inc. | 9 | $41,149 |
| Mylan Specialty L.p. | 3 | $21,170 |
| Astrazeneca UK Limited | 2 | $15,088 |
| Novartis | 1 | $7,425 |
| Amgen | 1 | $3,050 |
| Boehringer Ingelheim | 5 | $2,060 |
| Sunovion Pharmaceuticals Inc. | 8 | $88 |
| Actelion Pharmaceuticals US, Inc. | 4 | $76 |
| Merck | 3 | $66 |
| Regeneron Healthcare Solutions, Inc. | 3 | $64 |
| Abiomed | 1 | $60 |
| Philips North America LLC | 3 | $53 |
| Grifols USA, LLC | 2 | $37 |
| Electromed, Inc. | 2 | $34 |
| Getinge USA Sales, LLC | 1 | $33 |
| Genentech USA, Inc. | 2 | $33 |
| Body Vision Medical Inc. | 1 | $23 |
| Portola Pharmaceuticals, LLC | 1 | $21 |
| Resmed Corp | 1 | $17 |
| AbbVie | 1 | $17 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $15 |
| Insmed, Inc. | 1 | $12 |
How this compares
$4,403,606 in reported general payments places this provider in the 95th percentile of 190 critical care medicine providers in North Carolina.
See all critical care medicine providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Fayetteville
- Benjamin BregmanWinston Salem$2.1M
- Ashish KhannaWinston Salem$2M
- Reginald FowlerWinston-Salem$1.4M
- Kamrooz GhadimiDurham$1.1M
- Yuh Chin HuangDurham$936K
- Jason ThomasonWinston Salem$882K
- Alexis SmithHuntersville$726K
- Rabih BecharaCharlotte$465K
- Alan HeffnerCharlotte$326K
- Daniel FeinsteinPinehurst$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.